Literature DB >> 21123167

A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway.

Fabio Rabelo Melo1, Ida Waern, Elin Rönnberg, Magnus Åbrink, David M Lee, Susan M Schlenner, Thorsten B Feyerabend, Hans-Reimer Rodewald, Boris Turk, Sara Wernersson, Gunnar Pejler.   

Abstract

Mast cell secretory granules (secretory lysosomes) contain large amounts of fully active proteases bound to serglycin proteoglycan. Damage to the granule membrane will thus lead to the release of serglycin and serglycin-bound proteases into the cytosol, which potentially could lead to proteolytic activation of cytosolic pro-apoptotic compounds. We therefore hypothesized that mast cells are susceptible to apoptosis induced by permeabilization of the granule membrane and that this process is serglycin-dependent. Indeed, we show that wild-type mast cells are highly sensitive to apoptosis induced by granule permeabilization, whereas serglycin-deficient cells are largely resistant. The reduced sensitivity of serglycin(-/-) cells to apoptosis was accompanied by reduced granule damage, reduced release of proteases into the cytosol, and defective caspase-3 activation. Mechanistically, the apoptosis-promoting effect of serglycin involved serglycin-dependent proteases, as indicated by reduced sensitivity to apoptosis and reduced caspase-3 activation in cells lacking individual mast cell-specific proteases. Together, these findings implicate serglycin proteoglycan as a novel player in mast cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123167      PMCID: PMC3037655          DOI: 10.1074/jbc.M110.176461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways.

Authors:  P J Wolters; M Laig-Webster; G H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2000-02       Impact factor: 6.914

Review 2.  Mast cell proteases: multifaceted regulators of inflammatory disease.

Authors:  Gunnar Pejler; Elin Rönnberg; Ida Waern; Sara Wernersson
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

3.  A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components.

Authors:  Frida Henningsson; Sonja Hergeth; Robert Cortelius; Magnus Abrink; Gunnar Pejler
Journal:  FEBS J       Date:  2006-09-28       Impact factor: 5.542

4.  Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B.

Authors:  Mireille Laforge; Nicolas Bidère; Sylvie Carmona; Aurore Devocelle; Bernard Charpentier; Anna Senik
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 5.  Lysosomes as "suicide bags" in cell death: myth or reality?

Authors:  Boris Turk; Vito Turk
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

Review 6.  Lysosomal involvement in cell death and cancer.

Authors:  Thomas Kirkegaard; Marja Jäättelä
Journal:  Biochim Biophys Acta       Date:  2008-10-02

Review 7.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 8.  Are we ready to downregulate mast cells?

Authors:  Laila Karra; Beata Berent-Maoz; Micha Ben-Zimra; Francesca Levi-Schaffer
Journal:  Curr Opin Immunol       Date:  2009-12       Impact factor: 7.486

9.  Intracellular IL-15 controls mast cell survival.

Authors:  Farhad Mirghomizadeh; Supandi Winoto-Morbach; Zane Orinska; Kyeong-Hee Lee; Stefan Schütze; Silvia Bulfone-Paus
Journal:  Exp Cell Res       Date:  2009-07-23       Impact factor: 3.905

10.  Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.

Authors:  Jian Liu; Adeline Divoux; Jiusong Sun; Jie Zhang; Karine Clément; Jonathan N Glickman; Galina K Sukhova; Paul J Wolters; Juan Du; Cem Z Gorgun; Alessandro Doria; Peter Libby; Richard S Blumberg; Barbara B Kahn; Gökhan S Hotamisligil; Guo-Ping Shi
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

View more
  17 in total

Review 1.  Mast cell proteoglycans.

Authors:  Elin Rönnberg; Fabio R Melo; Gunnar Pejler
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

2.  Serglycin proteoglycan promotes apoptotic versus necrotic cell death in mast cells.

Authors:  Fabio R Melo; Mirjana Grujic; Jane Spirkoski; Gabriela Calounova; Gunnar Pejler
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 3.  Matrix proteoglycans in tumor inflammation and immunity.

Authors:  Gauri Deb; Alexander Cicala; Athanasios Papadas; Fotis Asimakopoulos
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-25       Impact factor: 5.282

4.  Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.

Authors:  Valerie C Wasinger; Yunki Yau; Xizi Duo; Ming Zeng; Beth Campbell; Sean Shin; Raphael Luber; Diane Redmond; Rupert W L Leong
Journal:  Mol Cell Proteomics       Date:  2015-11-03       Impact factor: 5.911

Review 5.  The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis.

Authors:  Devandir Antonio de Souza Junior; Ana Carolina Santana; Elaine Zayas Marcelino da Silva; Constance Oliver; Maria Celia Jamur
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

Review 6.  Serglycin in human cancers.

Authors:  Xin-Jian Li; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2011-09

Review 7.  Serglycin: at the crossroad of inflammation and malignancy.

Authors:  Angeliki Korpetinou; Spyros S Skandalis; Vassiliki T Labropoulou; Gianna Smirlaki; Argyrios Noulas; Nikos K Karamanos; Achilleas D Theocharis
Journal:  Front Oncol       Date:  2014-01-13       Impact factor: 6.244

Review 8.  Mast cell mediators: their differential release and the secretory pathways involved.

Authors:  Tae Chul Moon; A Dean Befus; Marianna Kulka
Journal:  Front Immunol       Date:  2014-11-14       Impact factor: 7.561

9.  Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes.

Authors:  Lee-Chin Chan; Jeevanathan Kalyanasundram; Sze-Wei Leong; Mas Jaffri Masarudin; Abhi Veerakumarasivam; Khatijah Yusoff; Soon-Choy Chan; Suet-Lin Chia
Journal:  BMC Cancer       Date:  2021-05-27       Impact factor: 4.430

10.  Nuclear receptor 4a3 (nr4a3) regulates murine mast cell responses and granule content.

Authors:  Gianni Garcia-Faroldi; Fabio R Melo; Dennis Bruemmer; Orla M Conneely; Gunnar Pejler; Anders Lundequist
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.